Dianthus Therapeutics, Inc. /DE/ Revenue Breakdown
No Revenue Breakdown for DNTH on this site yet.
- 2025-12-31: Others Not split by product in the filing$2.04M100.00%; Total revenue $2.04M.
- 2024-12-31: Others Not split by product in the filing$6.24M100.00%; Total revenue $6.24M.
- 2023-12-31: Others Not split by product in the filing$2.83M100.00%; Total revenue $2.83M.
- 2022-12-31: Others Not split by product in the filing$6.42M100.00%; Total revenue $6.42M.
Source checked: the stored Revenue Breakdown page for DNTH.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $2.04M 100.00% | $2.04M |
| 2024-12-31 | Not split by product in the filing $6.24M 100.00% | $6.24M |
| 2023-12-31 | Not split by product in the filing $2.83M 100.00% | $2.83M |
| 2022-12-31 | Not split by product in the filing $6.42M 100.00% | $6.42M |
| 2021-12-31 | Not split by product in the filing $1.48M 100.00% | $1.48M |
| 2019-12-31 | $0.00 | |
| 2018-12-31 | $0.00 | |
| 2017-12-31 | $0.00 | |
| 2016-12-31 | $0.00 |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product $284.00K 100.00% | $284.00K |
| 2025-09-30 | Not split by product $396.00K 100.00% | $396.00K |
| 2025-06-30 | Not split by product $193.00K 100.00% | $193.00K |
| 2025-03-31 | Not split by product $1.16M 100.00% | $1.16M |
| 2024-12-31 | Not split by product $1.33M 100.00% | $1.33M |
| 2024-09-30 | Not split by product $2.17M 100.00% | $2.17M |
| 2024-06-30 | Not split by product $1.86M 100.00% | $1.86M |
| 2024-03-31 | Not split by product $874.00K 100.00% | $874.00K |
| 2023-12-31 | Not split by product $457.00K 100.00% | $457.00K |
| 2023-09-30 | Not split by product $924.00K 100.00% | $924.00K |
| 2022-12-31 | Not split by product $1.18M 100.00% | $1.18M |
| 2022-09-30 | Not split by product $1.17M 100.00% | $1.17M |
| 2020-09-30 | Not split by product $0.00 | $0.00 |
| 2020-06-30 | Not split by product $0.00 | $0.00 |
| 2020-03-31 | Not split by product $0.00 | $0.00 |
| 2019-12-31 | Not split by product $0.00 | $0.00 |
| 2019-09-30 | Not split by product $0.00 | $0.00 |
| 2019-06-30 | Not split by product $0.00 | $0.00 |
| 2019-03-31 | Not split by product $0.00 | $0.00 |
| 2018-12-31 | Not split by product $0.00 | $0.00 |
| 2018-09-30 | Not split by product $0.00 | $0.00 |
| 2018-06-30 | Not split by product $0.00 | $0.00 |
| 2018-03-31 | Not split by product $0.00 | $0.00 |
| 2017-12-31 | Not split by product $0.00 | $0.00 |
| 2017-09-30 | Not split by product $0.00 | $0.00 |
| 2017-06-30 | Not split by product $0.00 | $0.00 |
| 2017-03-31 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |